Osteofibrous dysplasia and adamantinoma in children and adolescents: A clinicopathologic reappraisal

American Journal of Surgical Pathology

Volumn 32, Issue 3, 2008, Pages 363-376

  Gleason, Briana C ^a,b   Liegl Atzwanger, Bernadette ^b   Kozakewich, Harry P ^a   Connolly, Susan ^a   Gebhardt, Mark C ^a   Fletcher, Jonathan A ^a,b   Perez Atayde, Antonio R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone; Campanacci; Fibrous dysplasia; Tibia

Indexed keywords

KERATIN;

ADOLESCENT; ADULT; AMELOBLASTOMA; ARTICLE; BONE TUMOR; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; OSTEOFIBROUS DYSPLASIA; SPINDLE CELL; STROMA; TRISOMY;

ADAMANTINOMA; ADOLESCENT; ADULT; BIOPSY; BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA OF BONE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; MALE; OSTEOBLASTS; OSTEOCLASTS; RECURRENCE; TRISOMY;

EID: 40849136410     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318150d53e     Document Type: Article

References (56)

1. Albores-Saavedra J, Diaz-Gutierrez D, Altamirano-Dimas M. Adamantinoma de la tibia, observaciones ultrastructurales. Rev Med Hosp Gen. 1968;31:245.
2. Antonescu CR, Dal Cin P, Nafa K, et al. EWS-CREB1 is the predominant gene fusion in so-called angiomatoid fibrous histiocytoma. Mod Pathol. 2007;20(suppl 2):12A.
3. Benassi MS, Campanacci L, Gamberi G, et al. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis. Histopathology. 1994;25:71-76.
4. Bridge JA, Bhatia PS, Anderson JR, et al. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 1993;69:79-90.
5. Bridge JA, Dembinski A, DeBoer J, et al. Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer. 1994;73:1746-1752.
6. Bridge JA, Fidler ME, Neff JR, et al. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23:159-165.
7. Bridge JA, Swarts SJ, Buresh C, et al. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol. 1999;154:729-733.
8. Campanacci M, Laus M. Osteofibrous dysplasia of the tibia and fibula. J Bone Joint Surg Am. 1981;63:367-375.
9. Cohen DM, Dahlin DC, Pugh DG. Fibrous dysplasia associated with adamantinoma of the long bones. Cancer. 1962;15:515-521.
10. Czerniak B, Rojas-Corona RR, Dorfman HD. Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer. 1989;64:2319-2334.
11. Dei Tos AP, Doglioni C, Laurino L, et al. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopathology. 1993;22:45-50.
12. Eisenstein W, Pitcock JA. Adamantinoma of the tibia. An eccrine carcinoma. Arch Pathol Lab Med. 1984;108:246-250.
13. Fletcher CDM, Unni KK, Mertens F. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002:344-346.
14. Folpe AL, Goldblum JR, Rubin BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol. 2005;29:1025-1033.
15. Gaffney EF. Like - but oh, how different!. Am J Surg Pathol. 2000;24:322-323.
16. Haines JL, Korf BR, Morton CC, et al. Current Protocols in Human Genetics. New York: John Wiley & Sons, Inc; 2005:4.3.1-4.3.31.
17. Hatori M, Watanabe M, Hosaka M, et al. A classic adamantinoma arising from osteofibrous dysplasia-like adamantinoma in the lower leg: a case report and review of the literature. Tohoku J Exp Med. 2006;209:53-59.
18. Hazelbag HM, Fleuren GJ, vd Broek LJ, et al. Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. Am J Surg Pathol. 1993;17:1225-1233.
19. Hazelbag HM, Taminiau AH, Fleuren GJ, et al. Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am. 1994;76:1482-1499.
20. Hazelbag HM, Fleuren GJ, Cornelisse CJ, et al. DNA aberrations in the epithelial cell component of adamantinoma of long bones. Am J Pathol. 1995;147:1770-1779.
21. Hazelbag HM, Wessels JW, Mollevangers P, et al. Cytogenetic analysis of adamantinoma of long bones: further indications for a common histogenesis with osteofibrous dysplasia. Cancer Genet Cytogenet. 1997;97:5-11.
22. Ishida T, Iijima T, Kikuchi F, et al. A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol. 1992;21:493-502.
23. Ishida T, Kikuchi F, Oka T, et al. Case report 727. Juxtacortical adamantinoma of humerus (simulating Ewing tumor). Skeletal Radiol. 1992;21:205-209.
24. Kanamori M, Antonescu CR, Scott M, et al. Extra copies of chromosomes 7, 8, 12, 19, and 21 are recurrent in adamantinoma. J Mol Diagn. 2001;3:16-21.
25. Keeney GL, Unni KK, Beabout JW, et al. Adamantinoma of long bones. A clinicopathologic study of 85 cases. Cancer. 1989;64:730-737.
26. Knapp RH, Wick MR, Scheithauer BW, et al. Adamantinoma of bone. An electron microscopic and immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1982;398:75-86.
27. Konrad EA, Meister P, Stotz S. "Adamantinoma" of the tibia and reactive bone changes (author's transl). Arch Orthop Trauma Surg. 1978;92:297-301.
28. Kuruvilla G, Steiner GC. Osteofibrous dysplasia-like adamantinoma of bone: a report of five cases with immunohistochemical and ultrastructural studies. Hum Pathol. 1998;29:809-814.
29. Lee RS, Weitzel S, Eastwood DM, et al. Osteofibrous dysplasia of the tibia. Is there a need for a radical surgical approach? J Bone Joint Surg Br. 2006;88:658-664.
30. Levine SM, Lambiase RE, Petchprapa CN. Cortical lesions of the tibia: characteristic appearances at conventional radiography. Radiographics. 2003;23:157-177.
31. Maki M, Saitoh K, Kaneko Y, et al. Expression of cytokeratin 1, 5, 14, 19 and transforming growth factors-beta1, beta2, beta3 in osteofibrous dysplasia and adamantinoma: a possible association of transforming growth factor-beta with basal cell phenotype promotion. Pathol Int. 2000;50:801-807.
32. Mandahl N, Heim S, Rydholm A, et al. Structural chromosome aberrations in an adamantinoma. Cancer Genet Cytogenet. 1989;42:187-190.
33. Maurici D, Perez-Atayde A, Grier HE, et al. Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma. Cancer Genet Cytogenet. 1998;100:106-110.
34. Mirra J. Adamantinoma and osteofibrous dysplasia. In: Mirra JM, Picci P, Gold RH, eds. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Philadelphia: Lea & Febiger; 1989:1203-1231.
35. Mitelman F. ISCN (1995): An Internation System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 1995.
36. Mitelman F, Johnasson B, Mertens F. Mitelman database of chromosome aberrations in cancer. Available at: http://cgap.nci.gov/Chromosomes/Mitelman. Accessed June 2006.
37. Moon NF, Mori H. Adamantinoma of the appendicular skeleton - updated. Clin Orthop Relat Res. 1986;204:215-237.
38. Mori H, Yamamoto S, Hiramatsu K, et al. Adamantinoma of the tibia. Ultrastructural and immunohistochemic study with reference to histogenesis. Clin Orthop Relat Res. 1984;190:299-310.
39. Parham DM, Bridge JA, Lukacs JL, et al. Cytogenetic distinction among benign fibro-osseous lesions of bone in children and adolescents: value of karyotypic findings in differential diagnosis. Pediatr Dev Pathol. 2004;7:148-158.
40. Park YK, Unni KK, McLeod RA, et al. Osteofibrous dysplasia: clinicopathologic study of 80 cases. Hum Pathol. 1993;24:1339-1347.
41. Perez-Atayde AR, Kozakewich HP, Vawter GF. Adamantinoma of the tibia. An ultrastructural and immunohistochemical study. Cancer. 1985;55:1015-1023.
42. Pieterse AS, Smith PS, McClure J. Adamantinoma of long bones: clinical, pathological and ultrastructural features. J Clin Pathol. 1982;35:780-786.
43. Povysil C, Kohout A, Urban K, et al. Differentiated adamantinoma of the fibula: a rhabdoid variant. Skeletal Radiol. 2004;33:488-492.
44. Rosai J. Adamantinoma of the tibia. Electron microscopic evidence of its epithelial origin. Am J Clin Pathol. 1969;51:786-792.
45. Sarisozen B, Durak K, Ozturk C. Adamantinoma of the tibia in a nine-year-old child. Acta Orthop Belg. 2002;68:412-416.
46. Schajowicz F, Santini-Araujo E. Adamantinoma of the tibia masked by fibrous dysplasia. Report of three cases. Clin Orthop Relat Res. 1989;238:294-301.
47. Sozzi G, Miozzo M, Di Palma S, et al. Involvement of the region 13q14 in a patient with adamantinoma of the long bones. Hum Genet. 1990;85:513-515.
48. Springfield DS, Rosenberg AE, Mankin HJ, et al. Relationship between osteofibrous dysplasia and adamantinoma. Clin Orthop Relat Res. 1994;309:234-244.
49. Sweet DE, Vinh TN, Devaney K. Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma. A clinicopathologic study of 30 cases. Am J Surg Pathol. 1992;16:282-290.
50. Terra SB, Folpe AL, Weiss SW, et al. Frequency and characterization of ATF1- fusion genes in angiomatoid fibrous histiocytoma. Mod Pathol. 2007;20(suppl 2):21A.
51. Ueda Y, Roessner A, Bosse A, et al. Juvenile intracortical adamantinoma of the tibia with predominant osteofibrous dysplasia-like features. Pathol Res Pract. 1991;187:1039-1043. Discussion 1034-1043.
52. Unni KK, Dahlin DC, Beabout JW, et al. Adamantinomas of long bones. Cancer. 1974;34:1796-1805.
53. van Haelst UJ, de Haas van Dorsser AH. A perplexing malignant bone tumor. Highly malignant so-called adamantinoma or non-typical Ewing's sarcoma. Virchows Arch A Pathol Anat Histol. 1975;365:63-74.
54. Walts AE, Said JW, Koeffler HP. Is immunoreactivity for p53 useful in distinguishing benign from malignant effusions? Localization of p53 gene product in benign mesothelial and adenocarcinoma cells. Mod Pathol. 1994;7:462-468.
55. Weiss SW, Dorfman HD. Adamantinoma of long bone. An analysis of nine new cases with emphasis on metastasizing lesions and fibrous dysplasia-like changes. Hum Pathol. 1977;8:141-153.
56. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006;103:690-695.